Merck
MRK
#56
Rank
HK$2.119 T
Marketcap
HK$848.43
Share price
-1.93%
Change (1 day)
10.21%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): HK$59.18

According to Merck's latest financial reports the company's current EPS (TTM) is HK$59.20. In 2024 the company made an earnings per share (EPS) of HK$52.69 an increase over its 2023 EPS that were of HK$1.20.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$59.1812.31%
2024HK$52.694308.46%
2023HK$1.20-97.32%
2022HK$44.6710.92%
2021HK$40.2784.68%
2020HK$21.81-27.2%
2019HK$29.9563.44%
2018HK$18.33151.11%
2017HK$7.30-54.58%
2016HK$16.0730.21%
2015HK$12.34-61.99%
2014HK$32.46180.51%
2013HK$11.57-31.82%
2012HK$16.976.62%
2011HK$15.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.41-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.38 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.96 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.15-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.89-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
HK$28.03-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.91-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$57.38-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
HK$62.81 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.58 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA